Acadia Debuts New Team, Pipeline With ‘Biotech Powerhouse’ Ambitions

More than thirty years since its 1993 founding, Catherine Owen Adams and Elizabeth Thompson—the R&D combo that has led Acadia since last summer—are managing two products on the market and a pipeline estimated to be worth an additional $12 billion in sales.

Scroll to Top